ReviewJournal of nanobiotechnology2025

Current progress and remaining challenges of peptide-drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?

Dongyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.